8-OH-DPAT
| Clinical data | |
|---|---|
| Other names | 8-Hydroxy-2-(dipropylamino)tetralin; 8-Hydroxy-2-(di-n-propylamino)tetralin |
| Drug class | Serotonin 5-HT1A receptor agonist; Serotonin 5-HT7 receptor agonist; Serotonin reuptake inhibitor or releasing agent |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H25NO |
| Molar mass | 247.382 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (what is this?) (verify) | |
8-OH-DPAT, also known as 8-hydroxy-2-(dipropylamino)tetralin, is a serotonin 5-HT1A receptor agonist of the 2-aminotetralin family which was developed in the 1980s and has been widely used to study the function of the 5-HT1A receptor. It was one of the first major 5-HT1A receptor full agonists to have been discovered.
Originally believed to be selective for the 5-HT1A receptor, 8-OH-DPAT was later found to act as a serotonin 5-HT7 receptor agonist and serotonin reuptake inhibitor or releasing agent as well.
In animal studies, 8-OH-DPAT has been shown to possess antidepressant, anxiolytic, serenic (antiaggressive), anorectic, antiemetic, hypothermic, hypotensive, bradycardic, hyperventilative, and analgesic effects.